dexmedetomidine has been researched along with Experimental Spinal Cord Ischemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Liang, Y; Liu, B; Xiao, X; Zhang, H; Zhou, D | 1 |
| Arslan, M; Dursun, AD; Kavutçu, M; Köksal, Z; Kurtipek, Ö; Şengel, N; Sezen, ŞC | 1 |
| Cao, Y; Guo, H; Li, P; Liu, C; Wang, D; Yang, X; Zhai, M; Zhao, L | 1 |
| Chen, F; Jiang, Y; Li, X; Ma, H; Wang, D; Wang, H | 1 |
| Dai, J; Fan, X; Hu, J; Liu, J; Yuan, F; Zhang, S | 1 |
| Gao, Y; Lv, S; Masters, J; Sun, Z; Weng, H; Zhao, T | 1 |
| Bell, MT; Bennett, DT; Fullerton, DA; Herson, PS; Puskas, F; Quillinan, N; Reece, TB | 1 |
| Goyagi, T; Tobe, Y | 1 |
| Bell, MT; Cleveland, JC; Foley, LS; Freeman, KA; Fullerton, DA; Mares, J; Meng, X; Puskas, F; Reece, TB; Weyant, MJ | 1 |
| Bi, B; Fang, B; Li, XQ; Liu, G; Ma, H; Tan, WF; Zhang, Y | 1 |
| Agoston, VA; Bell, MT; Fullerton, DA; Meng, X; Puskas, F; Reece, TB; Smith, PD; Weyant, MJ | 1 |
| Maze, M; Sanders, RD | 1 |
| Davison, KJ; Higa, T; Kakinohana, M; Marsala, M; Nakamura, S; Oshiro, M; Saikawa, S; Sugahara, K | 1 |
14 other study(ies) available for dexmedetomidine and Experimental Spinal Cord Ischemia
| Article | Year |
|---|---|
Dexmedetomidine Attenuates Spinal Cord Ischemia-reperfusion Injury in Rabbits by Decreasing Oxidation and Apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Dexmedetomidine; Proto-Oncogene Proteins c-bcl-2; Rabbits; Reperfusion Injury; Spinal Cord Ischemia; Superoxide Dismutase | 2023 |
Effects of Dexmedetomidine Administered Through Different Routes on Kidney Tissue in Rats with Spinal Cord Ischaemia-Reperfusion Injury.
Topics: Animals; Dexmedetomidine; Kidney; Rats; Reperfusion Injury; Spinal Cord Ischemia | 2022 |
Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.
Topics: Animals; Apoptosis; Carrier Proteins; Caspases; Dexmedetomidine; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression; Male; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Spinal Cord; Spinal Cord Ischemia | 2019 |
Dexmedetomidine postconditioning alleviates spinal cord ischemia-reperfusion injury in rats via inhibiting neutrophil infiltration, microglia activation, reactive gliosis and CXCL13/CXCR5 axis activation.
Topics: Animals; Caspase 3; Dexmedetomidine; Gliosis; Interleukin-6; Microglia; Neutrophil Infiltration; Rats; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Tumor Necrosis Factor-alpha | 2023 |
Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Down-Regulation; HMGB1 Protein; Inflammation; Male; NF-kappa B; Rabbits; Reperfusion Injury; Signal Transduction; Spinal Cord Ischemia; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2019 |
Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
Topics: Animals; Apoptosis; Blood Pressure; Caspase 3; Dexmedetomidine; Female; Heart Rate; Inflammation; Male; Microglia; Models, Biological; Motor Activity; NF-kappa B; Rabbits; Reperfusion Injury; Signal Transduction; Spinal Cord Ischemia; Toll-Like Receptor 4 | 2018 |
Discussion.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Male; Neuroprotective Agents; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2014 |
Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Aorta, Thoracic; Brain-Derived Neurotrophic Factor; Constriction; CREB-Binding Protein; Dexmedetomidine; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Signal Transduction; Spinal Cord; Spinal Cord Ischemia; Time Factors | 2014 |
Dexmedetomidine improves the histological and neurological outcomes 48 h after transient spinal ischemia in rats.
Topics: Animals; Dexmedetomidine; Male; Motor Activity; Motor Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Ischemia | 2014 |
Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line-derived neurotrophic factor.
Topics: Animals; Astrocytes; Cell Culture Techniques; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred C57BL; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2015 |
Dexmedetomidine attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia reperfusion injury in rats.
Topics: Angiopoietin-1; Animals; Capillary Permeability; Dexmedetomidine; Disease Models, Animal; Injections, Spinal; Ischemic Preconditioning; Male; Matrix Metalloproteinase 9; Rats; Receptor, TIE-2; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2015 |
Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury; Spinal Cord Ischemia | 2012 |
Translational research: addressing problems facing the anesthesiologist.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesiology; Animals; Anterior Horn Cells; Biomedical Research; Dexmedetomidine; Humans; Morphine; Nerve Degeneration; Paraplegia; Rats; Spinal Cord Ischemia | 2007 |
Intravenous infusion of dexmedetomidine can prevent the degeneration of spinal ventral neurons induced by intrathecal morphine after a noninjurious interval of spinal cord ischemia in rats.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anterior Horn Cells; Dexmedetomidine; Dose-Response Relationship, Drug; Infusions, Intravenous; Injections, Spinal; Male; Morphine; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Spinal Cord Ischemia | 2007 |